Turk selected the collection’s three fabric designs, pairing them with her favorite Santa Barbara Umbrella colors, trims, and silhouettes to create the shading beauties available at the Trina Turk ...

February is shaping up to be a busy month for Buckhead Village, with several stores opening in the popular shopping and dining district.

Buckhead Village welcomes Roche Bobois, bringing high-end French furniture and home accessories to Atlanta’s luxury corridor.

The Toronto Interior Design Show, held from January 22 to 25 at the Metro Toronto Convention Centre, brought a welcome flash ...

Roche remains a Buy, driven by strong pipeline progress and conservative valuation, with shares up 36% since my last recommendation. CT388-103's Phase 2 obesity data show placebo-adjusted weight loss ...

Swiss pharmaceutical giant Roche announced positive results from a Phase II trial of its obesity drug CT-388, which showed significant weight loss. The company aims to advance to Phase III trials and ...

Roche obesity drug shows 22.5% weight loss in Phase-II trial Roche focuses on catching Lilly in $150 billion obesity market Investors lukewarm on CT-388 results in crowded market The company said on ...

Roche’s dual GLP-1/GIP receptor agonist has been tied to 22.5% weight loss at 48 weeks, validating the company’s decision to move the asset into phase 3 studies this quarter. The Swiss Big Pharma ...

Roche Holdings AG (OTC: RHHBY) on Tuesday released topline results from the CT388-103 Phase 2 trial of CT-388 for obesity. CT-388 is an investigational once-weekly subcutaneous injectable, dual ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Wondering whether Roche Holding's current share price still offers value, or if most ...

Roche’s dual agonist CT-388 achieves 22.5% weight loss in phase two trials, prompting acceleration and a bid to secure a strategic market position The Swiss pharmaceutical giant Roche has announced ...